Roman Butler Fullerton & Co’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68M | Buy |
3,577
+489
| +16% | +$230K | 0.5% | 47 |
|
|
2025
Q1 | $1.55M | Buy |
3,088
+1,521
| +97% | +$761K | 0.6% | 41 |
|
|
2024
Q4 | $695K | Sell |
1,567
-83
| -5% | -$36.8K | 0.22% | 106 |
|
|
2024
Q3 | $799K | Sell |
1,650
-1
| -0.1% | -$484 | 0.24% | 98 |
|
|
2024
Q2 | $811K | Buy |
1,651
+5
| +0.3% | +$2.46K | 0.26% | 88 |
|
|
2024
Q1 | $658K | Buy |
1,646
+301
| +22% | +$120K | 0.25% | 97 |
|
|
2023
Q4 | $578K | Sell |
1,345
-4,142
| -75% | -$1.78M | 0.23% | 110 |
|
|
2023
Q3 | $2.04M | Sell |
5,487
-410
| -7% | -$152K | 0.96% | 26 |
|
|
2023
Q2 | $2.11M | Buy |
5,897
+456
| +8% | +$163K | 0.97% | 25 |
|
|
2023
Q1 | $1.81M | Sell |
5,441
-492
| -8% | -$163K | 0.9% | 23 |
|
|
2022
Q4 | $1.85M | Sell |
5,933
-72
| -1% | -$22.5K | 0.96% | 22 |
|
|
2022
Q3 | $1.77M | Sell |
6,005
-602
| -9% | -$178K | 1.13% | 18 |
|
|
2022
Q2 | $1.94M | Buy |
6,607
+5,277
| +397% | +$1.55M | 1.07% | 20 |
|
|
2022
Q1 | $347K | Buy |
+1,330
| New | +$347K | 0.16% | 144 |
|
|
2021
Q3 | – | Sell |
-1,185
| Closed | -$239K | – | 197 |
|
|
2021
Q2 | $239K | Buy |
1,185
+223
| +23% | +$45K | 0.12% | 172 |
|
|
2021
Q1 | $213K | Buy |
+962
| New | +$213K | 0.11% | 191 |
|
|
2020
Q4 | – | Sell |
-4,008
| Closed | -$1.09M | – | 180 |
|
|
2020
Q3 | $1.09M | Sell |
4,008
-337
| -8% | -$91.7K | 0.71% | 45 |
|
|
2020
Q2 | $1.26M | Buy |
4,345
+38
| +0.9% | +$11K | 0.9% | 30 |
|
|
2020
Q1 | $1.03M | Buy |
4,307
+2,181
| +103% | +$519K | 0.9% | 31 |
|
|
2019
Q4 | $465K | Buy |
+2,126
| New | +$465K | 0.31% | 101 |
|
|
2019
Q1 | – | Sell |
-2,405
| Closed | -$447K | – | 185 |
|
|
2018
Q4 | $447K | Buy |
+2,405
| New | +$447K | 0.38% | 98 |
|